Fig. 2
Estimated OS (a) and TFS (b) for thalassemia patients receiving UD-HSCT and the OS (c) and TFS (d) for patients receiving MSD-HSCT in the NCR and CCR groups
Fig. 2 | Stem Cell Research & Therapy
Estimated OS (a) and TFS (b) for thalassemia patients receiving UD-HSCT and the OS (c) and TFS (d) for patients receiving MSD-HSCT in the NCR and CCR groups
Stem Cell Research & Therapy